Evidence map›Paper›PMID 38892521›Full record

ArticleNutrients2024

New Value of

Tomohiro Umeda, Ayumi Sakai, Keiko Shigemori, Kunio Nakata, Ryota Nakajima, Kei Yamana, Takami Tomiyama

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomohiro UmedaDepartment of Translational Neuroscience, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0000-0001-9915-623X
Ayumi SakaiDepartment of Translational Neuroscience, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Keiko ShigemoriDepartment of Translational Neuroscience, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.
Kunio NakataNOMON Co., Ltd., New Business Development Unit, Teijin Ltd., Kasumigaseki Common Gate West Tower 3-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-8585, Japan.ORCID 0000-0003-4318-3305
Ryota NakajimaNOMON Co., Ltd., New Business Development Unit, Teijin Ltd., Kasumigaseki Common Gate West Tower 3-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-8585, Japan.
Kei YamanaNOMON Co., Ltd., New Business Development Unit, Teijin Ltd., Kasumigaseki Common Gate West Tower 3-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100-8585, Japan.ORCID 0009-0009-5242-4300
Takami TomiyamaDepartment of Translational Neuroscience, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan.ORCID 0000-0001-6040-0178

Funding

Cerebro Pharma Inc. Not applicableTeijin Ltd. Not applicable
6 · The paper itself

Abstract

The rhizomes of

Indexed as

AcorusDementiaPlant ExtractsPlant LeavesAlzheimer DiseaseAmyloid beta-PeptidesAnimalsCognitionDisease Models, AnimalMaleMicetau ProteinsAmyloid beta-PeptidesPlant Extractstau ProteinsAcorus gramineus SolanderAcorus tatarinowii SchottAlzheimer’s diseasedementia with Lewy bodiesfrontotemporal dementiaprevention

Identifiers

PMID38892521
PMCPMC11175135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.